Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level

Agents Actions. 1993:39 Spec No:C67-9. doi: 10.1007/BF01972723.

Abstract

The mechanism by which SK&F 86002 and other pyridinyl imidazoles inhibit the production of IL-1 and TNF from LPS-stimulated human monocytes was examined. Inhibition of IL-1 and TNF production was found to depend on the time of addition of SK&F 86002, with diminishing effect when added more than 2 h after LPS stimulation. Analysis of Western blots confirmed that both intracellular IL-1 beta and extracellular TNF were significantly reduced in response to SK&F 86002, but these reductions were not paralleled by changes in IL-1 and TNF mRNA. 35S methionine pulse and pulse-chase studies on IL-1 biosynthesis suggest that significant inhibition by SK&F 86002 and related compounds occurs at the translational level.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Humans
  • Imidazoles / pharmacology*
  • Interleukin-1 / biosynthesis*
  • Interleukin-1 / genetics
  • Lipopolysaccharides / toxicity
  • Monocytes / drug effects*
  • Monocytes / metabolism
  • Protein Biosynthesis / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Thiazoles / pharmacology*
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Imidazoles
  • Interleukin-1
  • Lipopolysaccharides
  • RNA, Messenger
  • Thiazoles
  • Tumor Necrosis Factor-alpha
  • 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole